Evidence map›Paper›PMID 39267735›Full record

ArticleFrontiers in immunology2024

Case report: The histopathological analyses of two myelin oligodendrocyte glycoprotein antibody-associated diseases with a distinctive linear radiating gadolinium enhancement on MRI.

Mikito Shimizu, Goichi Beck, Shigeo Murayama, Taku Hoshi, Hiroyuki Sumikura, Kyoko Higashida, Isao Fukasaka, Yuki Shimada, Nozomi Nagashima, Tomohiro Fujioka and 4 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mikito ShimizuDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Goichi BeckDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Shigeo MurayamaDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Taku HoshiDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Hiroyuki SumikuraDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Kyoko HigashidaDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Isao FukasakaDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Yuki ShimadaDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Nozomi NagashimaDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Tomohiro FujiokaDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Naoki HatayamaDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.
Tatsusada OkunoDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Hideki MochizukiDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.
Manabu SakaguchiDepartment of Neurology, Osaka General Medical Center, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has highly heterogeneous clinical presentations, in which encephalitis is an important phenotype. Moreover, MOGAD has been reported to exhibit diverse imaging findings. However, there have been no previous reports of cases with perivascular radial gadolinium enhancement in periventricular regions, commonly reported in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. In this paper, we present two cases of MOGAD with this MRI feature, both of which underwent brain biopsy for the lesions. Brain biopsies revealed perivenous demyelination and inflammation consistent with acute disseminated encephalomyelitis (ADEM), with pronounced axonal damage in Case 1 and minimal axonal involvement in Case 2. Case 1 exhibited more severe cerebral atrophy than Case 2, correlating with the extent of axonal damage. Through these cases, we highlight the heterogeneity of radiological manifestations of MOGAD, expanding the spectrum beyond previously defined MRI patterns. Furthermore, histopathological analysis revealed distinct axonal involvement as a potential prognostic marker of brain atrophy. These observations emphasize the importance of considering MOGAD in the differential diagnosis, even in cases with atypical imaging findings, and highlight the significance of brain biopsy in guiding both diagnosis and prognosis.

Indexed as

AutoantibodiesGadoliniumMagnetic Resonance ImagingMyelin-Oligodendrocyte GlycoproteinAdultBiopsyBrainEncephalomyelitis, Acute DisseminatedFemaleHumansMaleMiddle AgedAutoantibodiesGadoliniumMOG protein, humanMyelin-Oligodendrocyte Glycoproteinaxonal damagebrain atrophyhistopathologyMRImyelin oligodendrocyte glycoprotein antibody-associated diseasethe radial linear periventricular enhancement pattern

Identifiers

PMID39267735
PMCPMC11390624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.